CATEGORIES

Medication

LATEST

TRENDING

EDITORS CHOICE

As Opioids Mixed With Animal Tranquilizers Arrive in Kensington, So Do Alarming Health Challenges

The neighborhood’s afflictions date to the early 1970s, when industry left and the drug trade took hold. With each new wave of drugs, the situation grows grimmer. Now, with the arrival of xylazine, a veterinary tranquilizer, new complications are burdening an already overtaxed system.

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

FDA Approval of New Drug for Alzheimer’s Offers Hope

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

The Future of Cardiovascular Disease Prevention: Insights from Drs. Eric Topol and Pradeep Natarajan

While LDL cholesterol remains a crucial target in cardiovascular prevention, it is important to look beyond this traditional marker.